Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Post by quinlashon Mar 28, 2024 10:51am
132 Views
Post# 35957949

CGC - My View

CGC - My ViewCanopy is still a beaten down stock IMHO with more room for shareprice recovery despite a jaw dropping week of gain

Here's why:

Germany has legalized and comes online April 1 - Canopy Medical is one of few established suppliers within the region and stand to gain well with incremental sales.

Canopy USA (the consolidation of 3 US companies under Canopy) is expected to be approved early / mid April.

The company has been making all the right moves to lean out the operation and position well for US launch. This has been grossly overlooked by the market for at least a year now 

The Vice President of the United States came out and publically backed cannabis. With 44 of 50 US states having some level of legal cannabis already the legalization in the US is all but a given at this point 

Historical multiplies for the stock and sector haven't even seen the surface scratched yet. Even the most modest historical multiple sets the shareprice substantially higher.

Sharecount is super low for this sector making supply and demand dynamics point to the potential for incredible squeeze potential 

.






<< Previous
Bullboard Posts
Next >>